Home › Occupations › Bioengineers and Biomedical Engineers › Seattle, WA
Bioengineers and Biomedical Engineers in Seattle, WA: H-1B salaries
24 labor condition applications for this occupation with a work site in Seattle, WA. Median offered base salary $84,431; middle half $74,250–$120,968.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $78,226 |
| Level II (qualified) | $87,861 |
| Level III (experienced) | $125,000 |
| Level IV (fully competent) | $170,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| University of Washington | 8 | $71,706 |
| Allen Institute | 3 | $82,742 |
| Keyamed Na Inc | 2 | $120,968 |
| Seattle Children's Hospital | 2 | $75,000 |
| Concord III, LLC | 1 | $222,000 |
| Devote Consulting Inc. | 1 | $170,000 |
| Novo Nordisk Research Center Seattle Inc. | 1 | $81,453 |
| Cartography Biosciences, Inc. | 1 | $130,000 |
| Food and Drug Administration | 1 | $109,546 |
| Key Proteo, Inc. | 1 | $95,722 |
| Becton, Dickinson and Company | 1 | $125,000 |
| InBios International, Inc. | 1 | $75,000 |
| Bristol-Myers Squibb Company | 1 | $294,662 |
Job titles
- Postdoctoral Scholar6
- Senior Imaging Engineer2
- Invent Fellow - PhD, Research2
- Scientist I2
- Scientific Data Engineer1
- Senior Product Manager1
- Senior Consultant1
- Engineer II1
- Data Scientist1
- Visiting Associate1
- Research Scientist1
- Sr. Quality Engineer1
- Research Scientist/Engineer 41
- Research Scientist/Engineer 21
- Quality Engineer I1
H-1B sponsors in Seattle, WA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).